Epidemic
Research on epidemic detailed by scientists at University of Leeds, Institute of Molecular and Cellular Biology
Published in TB and Outbreaks Week, May 29th, 2007
Researchers detail in "Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus," new data in epidemic. "Resistance to the antibiotic fusidic acid in European strains of Staphylococcus aureus causing impetigo has increased in recent years. This increase appears to have resulted from clonal expansion of a strain we have designated the epidemic European fusidic acid-resistant impetigo clone (EEFIC), which carries the fusidic acid resistance determinant fusB on its chromosome," scientists in Leeds, the United Kingdom report.
"To understand better the properties of the EEFIC responsible for its success, we have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Epidemic
Book Explores History, Causes of Allergy and Asthma Epidemic - West Nile Virus
UT Southwestern joins national clinical trial that seeks to uncover long-term effects of West Nile virus - Bird Flu
Intervet's Bird Flu Vaccine Receives EU License - Bird Flu
U.S. Preparedness to Respond to Avian Influenza a (H5N1) Strengthened by CDC/CSTE Partnership - Epidemic
Pulitzer Prize Winner Revisits Epicenter of Nation's Polio Epidemic - Flu Vaccines
Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1) - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
